Torrent Pharmaceuticals Limited — Others, 13-03-2025: Security Cover Certificate

Torrent Pharmaceuticals has announced a board meeting to review the financial results for the quarter and half-year ended December 31, 2024. The company reported a security cover of 1.95 times its outstanding non-convertible debentures, ensuring a solid backing for its debt obligations. This financial health position may bolster investor confidence, presenting a positive outlook while demonstrating the company’s capacity to manage its liabilities effectively. Overall, the results indicate a stable asset base, reflecting prudent management and an opportunity for continued growth in the pharmaceuticals sector.